Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was down 1.6% on Friday . The company traded as low as GBX 1.26 ($0.02) and last traded at GBX 1.38 ($0.02). Approximately 1,707,433 shares were traded during trading, an increase of 50% from the average daily volume of 1,135,592 shares. The stock had previously closed at GBX 1.40 ($0.02).
Cizzle Biotechnology Stock Up 6.2%
The business’s 50-day simple moving average is GBX 1.57 and its two-hundred day simple moving average is GBX 1.63. The stock has a market cap of £5.44 million, a P/E ratio of -1,925.76 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- 3 Dividend Kings To Consider
- 3 Energy Stocks to Gain Exposure to the Carbon Capture Boom
- What is the Dow Jones Industrial Average (DJIA)?
- AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Real Reason Ford Stock Is Rallying—Can It Keep Going?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
